Dermatitis - Open Access .click

Results 241 to 250 of about 163,209 (266)

Some of the next articles are maybe not open access.

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

Lancet, The, 2021
Andrew Blauvelt, D Thaçi, Chia Yu Chu
exaly

ATOPIJSKI DERMATITIS

2019
Atopijski dermatitis je česta kronična recidivirajuća upalna bolest koja se pojavljuje u osoba s atopijskom konstitucijom. Etiopatogeneza je složena i još nije u potpunosti. razjašnjena. Klinička slika se može nijenjati, od blagog to teškog oblika. Prirurčnik je nastao temeljem dugogodišnjeg kliničkog iskustva u liječenju djece i odraslih osoba.
Ljubojević Hadžavdić, Suzana, Pustišek, Nives +1 more
openaire +1 more source

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2021
Kristian Reich +2 more
exaly

Inflammatory Breast Cancer: The Disease, the Biology, the Treatment

Ca-A Cancer Journal for Clinicians, 2010
Luc M Bidaut, Wendy A Woodward, Anthony Lucci +2 more
exaly

Atopic dermatitis

Lancet, The, 2020
Sinead M Langan, Alan D Irvine, Stephan Weidinger +2 more
exaly

Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2022
exaly

Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial

Lancet, The, 2022
exaly

ATOPIC DERMATITIS

Archives of Dermatology, 1958
openaire +2 more sources